Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT. (Q54653887)

2 June 2018

title

Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT. (English)

1 reference

2 June 2018

main subject

radiation therapy

0 references

author

Matthias Guckenberger

series ordinal

1

1 reference

2 June 2018

author name string

I Lawrenz

series ordinal

2

1 reference

2 June 2018

M Flentje

series ordinal

3

1 reference

2 June 2018

publication date

8 November 2013

1 reference

2 June 2018

Strahlentherapie und Onkologie

published in

1 reference

2 June 2018

volume

190

1 reference

2 June 2018

issue

1

1 reference

2 June 2018

page(s)

48-53

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1007/s00066-013-0443-x

exact match

0 references

cites work

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

kV cone-beam CT-based IGRT: a clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-013-0443-X

Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer

21 January 2018

1 reference

12 December 2020

Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience

1 reference

12 December 2020

Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer

1 reference

12 December 2020

Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer

1 reference

12 December 2020

Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer

1 reference

12 December 2020

Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy

1 reference

12 December 2020

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

1 reference

12 December 2020

10.1007/S00066-013-0443-X

Identifiers

DOI

1 reference

2 June 2018

PubMed ID

24196279

1 reference

2 June 2018